EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The continuing search for effective treatments for older adults with acute myeloid leukemia

Xavier Thomas iD

Expert Review of Clinical Pharmacology · 2025

DOI: 10.1080/17512433.2025.2595682 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Xavier Thomas. Beteiligte Einrichtung: Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The goal of treatment in older patients (≥60 years) with acute myeloid leukemia (AML) has recently switched from only improving quality of life to achieving long-term survival via prolonged therapy. Novel therapeutic drugs have indeed recently been approved and tested in combination therapy. In this setting, the combination of venetoclax with a hypomethylating agent (HMA) has emerged as a new standard of care in this patient population. AREAS COVERED: This review summarizes promising emerging strategies combining target-directed agents for the treatment of older patients with AML. A comprehensive search was made on pubmed.ncbi.nlm.nih.gov, ashpublications.org, library.ehaweb.org, and clinicaltrials.gov to look for efficacy and safety of emerging therapeutic agents. EXPERT OPINION: Over the last 5 years, the landscape of AML therapy in older patients with AML has moved from uniform approaches toward more personalized therapy based on molecularly defined subtypes that benefit from target-directed therapy. Favorable results obtained with the synergistic combination venetoclax/HMA are currently opening a new active treatment research era by adding other specific drugs to this backbone regimen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsHumansAgedQuality of LifeMolecular Targeted TherapySulfonamidesBridged Bicyclo Compounds, HeterocyclicAge FactorsMiddle AgedPrecision MedicineSurvival Rate

Stichwörter der Autor:innen

Acute myeloid leukemiahypomethylating agentsolder patientsprognosistargeted therapyvenetoclax

Substanzen

venetoclaxSulfonamidesBridged Bicyclo Compounds, Heterocyclic

Autor:innen und Institutionen

  • Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.

ORCID-Profile: Xavier Thomas

Zitieren

APA

Thomas, X. (2025). The continuing search for effective treatments for older adults with acute myeloid leukemia. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2595682

Vancouver

Thomas X. The continuing search for effective treatments for older adults with acute myeloid leukemia. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2595682

BibTeX
@article{Thomas2025,
  author = {Thomas, Xavier},
  title = {The continuing search for effective treatments for older adults with acute myeloid leukemia},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2025},
  doi = {10.1080/17512433.2025.2595682}
}
Kostenlos starten →